Terms: = Gastric cancer AND AFP, AFPD, FETA, HPAFP AND Diagnosis
147 results:
1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. [A Case of Juvenile afp-Producing gastric cancer with Virchow Lymph Node Metastasis Achieved Long-Term Survival with Multimodal Therapy].
Ono HA; Suwa H; Minami Y; Nojiri K; Yoshida K; Masui H; Nagahori K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1892-1894. PubMed ID: 38303243
[TBL] [Abstract] [Full Text] [Related]
3. Alpha-fetoprotein-producing gastric cancer with ruptured liver metastasis mimicking hepatocellular carcinoma.
Kimura M; Matsuoka R; Nishikawa K; Imamura J; Kimura K
Clin J Gastroenterol; 2024 Apr; 17(2):234-239. PubMed ID: 38214832
[TBL] [Abstract] [Full Text] [Related]
4. Analysis and Prediction of Significant Genes in gastric cancer Based on TCGA Database.
Li R; Lu Y; Yi Z; An J
Stud Health Technol Inform; 2023 Nov; 308():445-454. PubMed ID: 38007771
[TBL] [Abstract] [Full Text] [Related]
5. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.
Yang X; Wu Y; Wang A; Ma X; Zhou K; Ji K; Ji X; Zhang J; Wu X; Li Z; Bu Z
J Pathol Clin Res; 2024 Jan; 10(1):e343. PubMed ID: 37974386
[TBL] [Abstract] [Full Text] [Related]
6. An autopsy case of alpha-fetoprotein-producing large duodenal adenocarcinoma.
Hirota S; Naganuma A; Kobayashi R; Suzuki Y; Hoshino T; Yasuoka H; Tanaka Y; Uraoka T; Kakizaki S
Clin J Gastroenterol; 2023 Dec; 16(6):829-835. PubMed ID: 37594614
[TBL] [Abstract] [Full Text] [Related]
7. [Liver metastasis from alpha-fetoprotein-producing gastric cancer 27 years postoperation:a case report].
Nakamura H; Takanashi K; Morita R; Sakurada A; Hirata Y; Komatsu Y; Osanai M; Katsuki S
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(7):602-609. PubMed ID: 37423731
[TBL] [Abstract] [Full Text] [Related]
8. Ribosomal DNA copy number alteration in blood sample from gastric cancer patients.
Chen C; Feng L; Chen J; Shen J; Lin L
Mol Biol Rep; 2023 Sep; 50(9):7155-7160. PubMed ID: 37407803
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of influencing factors of nerve invasion in locally advanced gastric cancer.
Ren XC; Liang P
Abdom Radiol (NY); 2023 Sep; 48(9):3005-3011. PubMed ID: 37289214
[TBL] [Abstract] [Full Text] [Related]
10. Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Li M; Mei YX; Wen JH; Jiao YR; Pan QR; Kong XX; Li J
Cancer Lett; 2023 Apr; 559():216104. PubMed ID: 36863507
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of an artificial neural network model for non-invasive gastric cancer screening and diagnosis.
Fan Z; Guo Y; Gu X; Huang R; Miao W
Sci Rep; 2022 Dec; 12(1):21795. PubMed ID: 36526664
[TBL] [Abstract] [Full Text] [Related]
12. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of Lens Culinaris Agglutinin-Reactive α-Fetoprotein in diagnosis of Malignant Tumors.
Jia Z; Xia J; Lu Q
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250825
[TBL] [Abstract] [Full Text] [Related]
14. A new biomarker for the early diagnosis of gastric cancer: gastric juice- and serum-derived SNCG.
Pan Y; Zheng Y; Yang J; Wei Y; Wu H; Liu S; Yin A; Hu J; Zeng Y
Future Oncol; 2022 Sep; 18(28):3179-3190. PubMed ID: 35947016
[TBL] [Abstract] [Full Text] [Related]
15. Electrochemical α-fetoprotein immunosensor based on Fe
Bölükbaşi ÖS; Yola BB; Karaman C; Atar N; Yola ML
Mikrochim Acta; 2022 Jun; 189(6):242. PubMed ID: 35654985
[TBL] [Abstract] [Full Text] [Related]
16. Carcinosarcoma of the stomach: four cases that expand the morphologic spectrum of gastric cancer with a primitive phenotype.
Yamazawa S; Ushiku T
Virchows Arch; 2022 May; 480(5):1051-1062. PubMed ID: 35243539
[TBL] [Abstract] [Full Text] [Related]
17. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients.
Chen Y; Zhang J; Liu J; Wang J; Shi C; Lu L; Cheng X; Niu G; Zhang S
J Immunol Res; 2022; 2022():1817694. PubMed ID: 35224110
[TBL] [Abstract] [Full Text] [Related]
18. Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular cancer.
Cao LL; Han Y; Wang Y; Pei L; Yue Z; Qin L; Liu B; Cui J; Jia M; Wang H
Front Endocrinol (Lausanne); 2021; 12():816748. PubMed ID: 35154012
[TBL] [Abstract] [Full Text] [Related]
19. Pitfalls in the diagnosis of yolk sac tumor: Lessons from a clinical trial.
Yang A; Patterson A; Pavlock T; Chen KS; Gagan J; Hatley ME; Frazier AL; Amatruda JF; Laetsch TW; Rakheja D
Pediatr Blood Cancer; 2022 Feb; 69(2):e29451. PubMed ID: 34866303
[TBL] [Abstract] [Full Text] [Related]
20. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.
Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J
Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546
[TBL] [Abstract] [Full Text] [Related]
[Next]
